Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alida Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Alida Biosciences

Alida Biosciences

Alida Biosciences: Pioneering next-gen RNA analysis tools for advanced medical treatments & diagnostics.

HQ
San Diego, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize RNA analysis, Alida Biosciences is dedicated to developing cutting-edge tools for advanced medical treatments and diagnostic assays. The company focuses on creating next-generation epigenetic analysis technology, which aims to empower research, therapeutics, and diagnostics by understanding complex gene regulation relationships. Their products include early access reagent kits for multiplexed epitranscriptome analysis, catering to the needs of the medical and scientific research communities.

Alida Biosciences has attracted notable investors and affiliated experts in the field of biotechnology and genomics. The company's pioneering efforts have led to significant advancements in multiomics tools for epigenomic discovery, positioning them as a leader in the RNA analysis space. Their innovative solutions have had a substantial impact on the ability to conduct detailed genetic and epigenetic research, paving the way for new medical breakthroughs and improved diagnostic capabilities.

Alida Biosciences - Similar Companies

Aldena Therapeutics logo

Aldena Therapeutics

Epic-Bio logo

Epic-Bio

epic-bio.com

Wayfinder Biosciences logo

Wayfinder Biosciences

wayfinderbio.com

RealSeq Biosciences logo

RealSeq Biosciences

Epigentek Group logo

Epigentek Group

epigentek.com

Alaya.bio logo

Alaya.bio

alaya.bio

Alltrna logo

Alltrna

alltrna.com

Accelevir Diagnostics logo

Accelevir Diagnostics

Aldatu Biosciences logo

Aldatu Biosciences

aldatubio.com

Inceptive logo

Inceptive

inceptive.life

AtlasXomics logo

AtlasXomics

atlasxomics.com

Element Biosciences logo

Element Biosciences

Eclipse Bioinnovations logo

Eclipse Bioinnovations

eclipsebio.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Exai Bio logo

Exai Bio

exai.bio

Alida Biosciences - Quick Facts

Who are Alida Biosciences' competitors?

Companies similar to Alida Biosciences include Aldena Therapeutics, Epic-Bio, Wayfinder Biosciences and RealSeq Biosciences.

When was Alida Biosciences founded?

Alida Biosciences was founded in 2020.

Where is Alida Biosciences' headquarters located?

Alida Biosciences' headquarters is located in San Diego, CA, US.

When was Alida Biosciences' last funding round?

Alida Biosciences' most recent funding round was for $4M (USD) in May 2022.

How much has Alida Biosciences raised to-date?

As of May 11, 2022, Alida Biosciences has raised a total of $5.1M (USD).

How many employees does Alida Biosciences have?

Alida Biosciences has 16 employees as of Feb 5, 2024.

Alida Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • RNA Analysis
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research